11:45 AM EST - Cardiome Pharma Corp : and CarCor Investment Holdings LLC, the shareholder from which Cardiome purchased Correvio LLC, are pleased to announce that they have entered into an agreement with a group of underwriters led by Canaccord Genuity Corp. for the sale, on a bought deal basis, of 1,500,000 common shares from Cardiome for gross proceeds of $15 million and 1,500,000 common shares in a secondary offering from Carcor for gross proceeds of $15 million both at $10.00 per common share, for a combined offering of $30 million. Cardiome Pharma Corp
shares T.COM are trading down $0.84 at $10.60.
